Skip to main content

Table 3 Quality assessment checklist

From: Efficacy and safety of a bridging strategy that uses intravenous platelet glycoprotein receptor inhibitors for patients undergoing surgery after coronary stent implantation: a meta-analysis

18-Criteria checklist

Number of studies saying yes

Number of studies saying no

1. Is the hypothesis/aim/objective of the study stated clearly in the abstract, introduction, or methods section?

10

0

2. Are the characteristics of the participants included in the study described?

10

0

3. Were the cases collected in more than one center?

2

8

4. Are the eligibility criteria (inclusion and exclusion criteria) for entry into the study explicit and appropriate?

10

0

5. Were participants recruited consecutively?

7

3

6. Did participants enter the study at a similar point in the disease?

8

2

7. Was the intervention clearly described in the study?

10

0

8. Were additional interventions (co-interventions) clearly reported in the study?

10

0

9. Are the outcome measures clearly defined in the introduction or methods section?

10

0

10. Were relevant outcomes appropriately measured with objective and/or subjective methods?

9

1

11. Were outcomes measured before and after intervention?

8

2

12. Were the statistical tests used to assess the relevant outcomes appropriate?

7

3

13. Was the length of follow-up reported?

5

5

14. Was the loss to follow-up reported?

10

0

15. Does the study provide estimates of the random variability in the data analysis of relevant outcomes?

8

2

16. Are adverse events reported?

10

0

17. Are the conclusions of the study supported by results?

10

0

18. Are both competing interests and sources of support for the study reported?

10

0